These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30793629)

  • 1. Deciphering protective immunity against tuberculosis: implications for vaccine development.
    Counoupas C; Triccas JA; Britton WJ
    Expert Rev Vaccines; 2019 Apr; 18(4):353-364. PubMed ID: 30793629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The generation of T-cell memory to protect against tuberculosis.
    Counoupas C; Triccas JA
    Immunol Cell Biol; 2019 Aug; 97(7):656-663. PubMed ID: 31127962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice.
    Chuang YM; Pinn ML; Karakousis PC; Hung CF
    Front Cell Infect Microbiol; 2018; 8():31. PubMed ID: 29473022
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine Design.
    Ernst JD
    Cell Host Microbe; 2018 Jul; 24(1):34-42. PubMed ID: 30001523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).
    Churchyard GJ; Snowden MA; Hokey D; Dheenadhayalan V; McClain JB; Douoguih M; Pau MG; Sadoff J; Landry B
    Vaccine; 2015 Apr; 33(15):1890-6. PubMed ID: 25698492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond memory T cells: mechanisms of protective immunity to tuberculosis infection.
    Steigler P; Verrall AJ; Kirman JR
    Immunol Cell Biol; 2019 Aug; 97(7):647-655. PubMed ID: 31141205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
    Khademi F; Derakhshan M; Yousefi-Avarvand A; Tafaghodi M; Soleimanpour S
    Expert Rev Vaccines; 2018 Jan; 17(1):31-44. PubMed ID: 29148853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
    Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
    Front Immunol; 2018; 9():2371. PubMed ID: 30386336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of clinical models for the evaluation of human TB vaccines.
    O'Shea MK; McShane H
    Hum Vaccin Immunother; 2016 May; 12(5):1177-87. PubMed ID: 26810964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quest for correlates of protection against tuberculosis.
    Bhatt K; Verma S; Ellner JJ; Salgame P
    Clin Vaccine Immunol; 2015 Mar; 22(3):258-66. PubMed ID: 25589549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of new tuberculosis vaccine in children.
    Pang Y; Zhao A; Cohen C; Kang W; Lu J; Wang G; Zhao Y; Zheng S
    Hum Vaccin Immunother; 2016 Apr; 12(4):960-70. PubMed ID: 27002369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of B Cells in Mucosal Vaccine-Induced Protective CD8+ T Cell Immunity against Pulmonary Tuberculosis.
    Khera AK; Afkhami S; Lai R; Jeyanathan M; Zganiacz A; Mandur T; Hammill J; Damjanovic D; Xing Z
    J Immunol; 2015 Sep; 195(6):2900-7. PubMed ID: 26268652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies and tuberculosis.
    Jacobs AJ; Mongkolsapaya J; Screaton GR; McShane H; Wilkinson RJ
    Tuberculosis (Edinb); 2016 Dec; 101():102-113. PubMed ID: 27865379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination.
    Bitencourt J; Peralta-Álvarez MP; Wilkie M; Jacobs A; Wright D; Salman Almujri S; Li S; Harris SA; Smith SG; Elias SC; White AD; Satti I; Sharpe SS; O'Shea MK; McShane H; Tanner R
    Front Immunol; 2021; 12():798207. PubMed ID: 35069580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
    Wu M; Li M; Yue Y; Xu W
    Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON(®)-TB Gold (+) Kenyan adults without evidence of tuberculosis.
    Walsh DS; Owira V; Polhemus M; Otieno L; Andagalu B; Ogutu B; Waitumbi J; Hawkridge A; Shepherd B; Pau MG; Sadoff J; Douoguih M; McClain JB;
    Vaccine; 2016 May; 34(21):2430-2436. PubMed ID: 27026148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.